Pro-inflammatory genetic background and zinc status in old atherosclerotic subjects

Ageing Research Reviews

Volumn 7, Issue 4, 2008, Pages 306-318

  Giacconi, Robertina ^a   Caruso, Calogero ^b   Malavolta, Marco ^a   Lio, Domenico ^b   Balistreri, Carmela R ^b   Scola, Letizia ^b   Candore, Giuseppina ^b   Muti, Elisa ^a   Mocchegiani, Eugenio ^a  

^a Research Department   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Atherosclerosis; Elderly; Inflammation; Polymorphisms; Zinc status

Indexed keywords

BIOLOGICAL MARKER; CD14 ANTIGEN; HEAT SHOCK PROTEIN 70; INTERLEUKIN 10; INTERLEUKIN 6; METALLOTHIONEIN; PRAVASTATIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ZINC; ZINC ASPARTATE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL PROTECTION; CLINICAL TRIAL; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE PREDISPOSITION; ELDERLY CARE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALABSORPTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; SHORT SURVEY; SIDE EFFECT; ZINC DEFICIENCY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; HOMEOSTASIS; HUMANS; INFLAMMATION; METALLOTHIONEIN; OXIDATIVE STRESS; ZINC;

EID: 53049090818     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2008.06.001     Document Type: Short Survey

References (206)

1. Abel J., and de Ruiter N. Inhibition of hydroxyl-radical-generated DNA degradation by metallothionein. Toxicol. Lett. 47 (1989) 191-196
2. Amar J., Ruidavets J.B., Bal dit Sollier C., Bongard V., Boccalon H., Chamontin B., Drouet L., and Ferrières J. CD14 C(-260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis. J. Hypertens. 22 (2004) 1523-1528
3. Ambra R., Mocchegiani E., Giacconi R., Canali R., Rinna A., Malavolta M., and Virgili F. Characterization of the hsp70 response in lymphoblasts from aged and centenarian subjects and differential effects of in vitro zinc supplementation. Exp. Gerontol. 39 (2004) 1475-1484
4. Ameziane N., Beillat T., Verpillat P., Chollet-Martin S., Aumont M.C., Seknadji P., Lamotte M., Lebret D., Ollivier V., and de Prost D. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 61-64
5. Andrews G.K. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem. Pharmacol. 59 (2000) 95-104
6. Antonicelli R., Olivieri F., Cavallone L., Spazzafumo L., Bonafé M., Marchegiani F., Cardelli M., Giovagnetti S., Perna G.P., and Franceschi C. Tumor necrosis factor-alpha gene -308G → A polymorphism is associated with ST-Elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron. Artery Dis. 16 (2005) 489-493
7. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., and Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25 (2000) 187-191
8. Arroyo-Espliguero R., El-Sharnouby K., Vazquez-Rey E., Kalidas K., Jeffery S., and Kaski J.C. CD14 C (-260) T promoter polymorphism and prevalence of acute coronary syndromes. Int. J. Cardiol. 98 (2005) 307-312
9. Asea A. Chaperokine-induced signal transduction pathways. Exer. Immunol. Rev. 9 (2003) 25-33
10. Asea A., Kraeft S.K., Kurt-Jones E.A., Stevenson M.A., Chen L.B., Finberg R.W., Koo G.C., and Calderwood S.K. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6 (2000) 435-442
11. Auer J., Weber T., Berent R., Lassnig E., Lamm G., and Eber B. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am. J. Pharmacogenom. 3 (2003) 317-328
12. Balistreri C.R., Candore G., Colonna-Romano G., Franceschi C., and Caruso C. Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 292 (2004) 2339-2340
13. Barbato J.C., Catanescu O., Murray K., DiBello P.M., and Jacobsen D.W. Targeting of metallothionein by l-homocysteine: a novel mechanism for disruption of zinc and redox homeostasis. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 49-54
14. Barton B.E. The biological effects of interleukin 6. Med. Res. Rev. 16 (1996) 87-109
15. Beattie J.H., and Kwun I.S. Is zinc deficiency a risk factor for atherosclerosis?. Br. J. Nutr. 91 (2004) 177-181
16. Beere, H.M., 2001. Stressed to death: regulation of apoptotic signaling pathways by the heat shock proteins. Sci. STKE 93, RE1.
17. Bennermo M., Held C., Green F., Strandberg L.E., Ericsson C.G., Hansson L.O., Watkins H., Hamsten A., and Tornvall P. Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis 174 (2004) 157-163
18. Bernard V., Pillois X., Dubus I., Benchimol D., Labouyrie J.P., Couffinhal T., Coste P., and Bonnet J. The -308 G/A tumor necrosis factor-alpha gene dimorphism: a risk factor for unstable angina. Clin. Chem. Lab. Med. 41 (2003) 511-516
19. Bjorkbacka H. Multiple roles of Toll-like receptor signaling in atherosclerosis. Curr. Opin. Lipidol. 17 (2006) 527-533
20. Blum A., and Miller H. Role of cytokines in heart failure. Am. Heart J. 135 (1998) 181-186
21. Bo S., Durazzo M., Gambino R., Berutti C., Milanesio N., Caropreso A., Gentile L., Cassader M., Cavallo-Perin P., and Pagano G. Associations of dietary and serum copper with inflammation, oxidative stress, and metabolic variables in adults. J. Nutr. 138 (2008) 305-310
22. Bobryshev Y.V., and Lord R.S. Expression of heat shock protein-70 by dendritic cells in the arterial intima and its potential significance in atherogenesis. J. Vasc. Surg. 35 (2002) 368-375
23. Boekholdt S.M., Agema W.R., Peters R.J., Zwinderman A.H., van der Wall E.E., Reitsma P.H., Kastelein J.J., and Jukema J.W. REgression GRowth Evaluation Statin Study Group Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 107 (2003) 2416-2421
24. Bonafe M., Olivieri F., Cavallone L., Giovagnetti S., Mayegiani F., Cardelli M., Pieri C., Marra M., Antonicelli R., Lisa R., Rizzo M.R., Paolisso G., Monti D., and Franceschi C. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur. J. Immunol. 31 (2008) 2357-2361
25. Bonelli M.A., Alfieri R.R., Poli M., Petroniani P.G., and Borghetti A.F. Heat-induced proteasomic degradation of HSF1 in serum-starved human fibroblasts aging in vitro. Exp. Cell. Res. 267 (2001) 165-172
26. Boukaiba N., Flament C., Acher S., Chappuis P., Piau A., Fusselier M., Dardenne M., and Lemonnier D. A physiological amount of zinc supplementation: effects on nutritional, lipid, and thymic status in an elderly population. Am. J. Clin. Nutr. 57 (1993) 566-572
27. Bruunsgaard H., Pederson M., and Pederson B.K. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 8 (2001) 131-136
28. Cabreiro F., Perichon M., Jatje J., Malavolta M., Mocchegiani E., Friguet B., and Petropoulos I. Zinc supplementation in the elderly subjects: effect on oxidized protein degradation and repair systems in peripheral blood lymphocytes. Exp. Gerontol. 43 (2008) 483-487
29. Caruso C., Candore G., Colonna-Romano G., Lio D., and Franceschi C. Inflammation and life-span. Science 307 (2005) 208-209
30. Chapman C.M., Beilby J.P., Humphries S.E., Palmer L.J., Thompson P.L., and Hung J. Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population. Eur. Heart J. 24 (2003) 1494-1499
31. Chase M.A., Wheeler D.S., Lierl K.M., Hughes V.S., Wong H.R., and Page K. Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4- and NF-kappaB-dependent mechanism. J. Immunol. 179 (2007) 6318-6324
32. Chen Y., Irie Y., Keung W.M., and Maret W. S-nitrosothiols react preferentially with zinc thiolate clusters of metallothionein III through transnitrosation. Biochemistry 41 (2002) 8360-8367
33. Cheng Y., Liu Y.F., and Liang J. Protective effect of zinc: a potent heat shock protein inducer in cold preservation of rat liver. Hepatobiliary Pancreat. Dis. Int. 1 (2002) 258-261
34. Choy J.C., Granville D.J., Hunt D.W., and McManus B.M. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J. Mol. Cell. Cardiol. 33 (2001) 1673-1690
35. Cipriano C., Caruso C., Lio D., Giacconi R., Malavolta M., Muti E., Gasparini N., Franceschi C., and Mocchegiani E. The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases. Int. J. Immunogenet. 32 (2005) 13-18
36. Cipriano C., Malavolta M., Costarelli L., Giacconi R., Muti E., Gasparini N., Cardelli M., Monti D., Mariani E., and Mocchegiani E. Polymorphisms in MT1a gene coding region are associated with longevity in Italian Central female population. Biogerontology 7 (2006) 357-365
37. Cousins R.J., Liuzzi J.P., and Lichten L.A. Mammalian zinc transport, trafficking, and signals. J. Biol. Chem. 281 (2006) 24085-24089
38. Crawley E., Kay R., Sillibourne J., Patel P., Hutchinson I., and Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis. Rheum. 42 (1999) 1101-1108
39. Daigle I., Rückert B., Schnetzler G., and Simon H.U. Induction of the IL-10 gene via the fas receptor in monocytes-an anti-inflammatory mechanism in the absence of apoptosis. Eur. J. Immunol. 30 (2000) 2991-2997
40. D'Alfonso S., Rampi M., Rolando V., Giordano M., and Momigliano-Richiardi P. New polymorphisms in the IL-10 promoter region. Genes Immun. 1 (2000) 231-233
41. Davis S.R., and Cousins R.J. Metallothionein expression in animals: a physiological perspective on function. J. Nutr. 130 (2000) 1085-1088
42. de la Torre P., Diaz-Sanjuan T., Garcia-Ruiz I., Esteban E., Canga F., Munoz-Yague T., and Solis-Herruzo J.A. Interleukin-6 increases rat metalloproteinase-13 gene expression through Janus kinase-2-mediated inhibition of serine/threonine phosphatase-2A. Cell. Signal. 17 (2005) 427-435
43. De Martinis M., Franceschi C., Monti D., and Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett. 579 (2005) 2035-2039
44. Delogu G., Signore M., Mechelli A., and Famularo G. Heat shock proteins and their role in heart injury. Curr. Opin. Crit. Care 8 (2002) 411-416
45. Donger C., Georges J.L., Nicaud V., Morrison C., Evans A., Kee F., Arveiler D., Tiret L., and Cambien F. New polymorphisms in the interleukin-10 gene-relationships to myocardial infarction. Eur. J. Clin. Invest. 31 (2001) 9-14
46. Driessler F., Venstrom K., Sabat R., Asadullah K., and Schottelius A.J. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin. Exp. Immunol. 135 (2004) 64-73
47. Dybdahl B., Slordahl S.A., Waage A., Kierulf P., Espevik T., and Sundan A. Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart 91 (2005) 299-304
48. Eby G.A., and Halcomb W.W. High-dose zinc to terminate angina pectoris: a review and hypothesis for action by ICAM inhibition. Med. Hypotheses 66 (2006) 169-172
49. Edfeldt K., Bennet A.M., Eriksson P., Frostegard J., Wiman B., Hamsten A., Hansson G.K., de Faire U., and Yan Z.Q. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur. Heart J. 25 (2004) 1447-1453
50. Elneihoum A.M., Falke P., Hedblad B., Lindgärde F., and Ohlsson K. Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis 131 (1997) 79-84
51. Faure E., Thomas L., Xu H., Medvedev A., Equils O., and Arditi M. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J. Immunol. 166 (2001) 2018-2024
52. Finamore A., Devirgiliis C., Panno D., D'Aquino M., Polito A., Venneria E., Raguzzini A., Coudray C., and Mengheri E. Immune response in relation to zinc status, sex and antioxidant defence in Italian elderly population: the ZENITH study. Eur. J. Clin. Nutr. 59 (2005) S68-72
53. Giacconi R., Bonfigli A.R., Testa R., Sirolla C., Cipriano C., Muti E., Marra M., Malavolta M., Costarelli L., Piacenza F., Tesei S., and Mocchegiani E. +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol. Genet. Metab. 94 (2008) 98-104
54. Giacconi R., Caruso C., Lio D., Muti E., Cipriano C., Costarelli L., Saba V., Gasparini N., Malavolta M., and Mocchegiani E. CD14 C (-260)T polymorphism, atherosclerosis, elderly: role of cytokines and metallothioneins. Int. J. Cardiol. 120 (2007) 45-51
55. Giacconi R., Caruso C., Lio D., Muti E., Cipriano C., Saba V., Boccoli G., Gasparini N., Malavolta M., and Mocchegiani E. 1267 HSP70-2 polymorphism as a risk factor for carotid plaque rupture and cerebral ischaemia in old type 2 diabetes-atherosclerotic patients. Mech. Ageing Dev. 126 (2005) 866-873
56. Giacconi R., Cipriano C., Albanese F., Boccoli G., Saba V., Olivieri F., Franceschi C., and Mocchegiani E. -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp. Gerontol. 39 (2004) 621-628
57. Giacconi R., Cipriano C., Muti E., Costarelli L., Malavolta M., Caruso C., Lio D., and Mocchegiani E. Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients. Biogerontology 7 (2006) 347-356
58. Giacconi R., Cipriano C., Muti E., Costarelli L., Maurizio C., Saba V., Gasparini N., Malavolta M., and Mocchegiani E. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 6 (2005) 407-413
59. Giacconi R., Muti E., Malavolta M., Cipriano C., Costarelli L., Bernardini G., Gasparini N., Mariani E., Saba V., Boccoli G., and Mocchegiani E. The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people. Mol. Med. 13 (2007) 388-395
60. Gibson A.W., Edberg J.C., Wu J., Westendorp R.G., Huizinga T.W., and Kimberly R.P. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J. Immunol. 166 (2001) 3915-3922
61. Girndt M., Kaul H., Sester U., Ulrich C., Sester M., Georg T., and Kohler H. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int. 62 (2002) 949-955
62. Haase H., Mazzatti D.J., White A., Ibs K.H., Engelhardt G., Hebel S., Powell J.R., and Rink L. Differential gene expression after zinc supplementation and deprivation in human leukocyte subsets. Mol. Med. 13 (2007) 362-370
63. Haddy N., Sass C., Maumus S., Marie B., Droesch S., Siest G., Lambert D., and Visvikis S. Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort. Eur. J. Hum. Genet. 13 (2005) 109-117
64. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Boersma E., Simoons M.L., and Zeiher A.M. CAPTURE Study Investigators Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107 (2003) 2109-2114
65. Hennig B., Meerarani P., Toborek M., and McClain C.J. Antioxidant-like properties of zinc in activated endothelial cells. J. Am. Coll. Nutr. 18 (1999) 152-158
66. Herbein G., Varin A., and Fulop T. NF-kappaB, AP-1 zinc-deficiency and aging. Biogerontology 7 (2006) 409-419
67. Hernesniemi J.A., Raitakari O.T., Kähönen M., Juonala M., Hutri-Kähönen N., Marniemi J., Viikari J., and Lehtimäki T. Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity. The cardiovascular risk in young Finns study. Atherosclerosis 198 (2008) 152-159
68. Heuchel R., Radtke F., Georgiev O., Stark G., Aguet M., and Schaffner W. The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. EMBO J. 13 (1994) 2870-2875
69. Heumann D., Glauser M.P., and Calandra T. Molecular basis of host-pathogen interaction in septic shock. Curr. Opin. Microbiol. 1 (1998) 49-55
70. Ho E., and Ames B.N. Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 16770-16775
71. Hoffmann S.C., Stanley E.M., Darrin, Cox E., Craighead N., DiMercurio B.S., Koziol D.E., Harlan D.M., Kirk A.D., and Blair P.J. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 72 (2001) 1444-1450
72. Hohda S., Kimura A., Sasaoka T., Hayashi T., Ueda K., Yasunami M., Okabe M., Fukuta N., Kurosawa T., and Izumi T. Association study of CD14 polymorphism with myocardial infarction in a Japanese population. Jpn. Heart J. 44 (2003) 613-622
73. Holloway J.W., Yang I.A., and Ye S. Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction. Pharmacogenet. Genom. 15 (2005) 15-21
74. Holmes C.L., Russell J.A., and Walley K.R. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 124 (2003) 1103-1115
75. Hu X., Yee E., Harlan J.M., Wong F., and Karsan A. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood 92 (1998) 2759-2765
76. Hubacek J.A., Rothe G., Pit'ha J., Skodova Z., Stanek V., Poledne R., and Schmitz G. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99 (1999) 3218-3220
77. Huber S.A., Sakkinen P., Conze D., Hardin N., and Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2364-2367
78. Hughes S., and Samman S. The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis. J. Am. Coll. Nutr. 25 (2006) 285-291
79. Ikeda U., Ito T., and Shimada K. Interleukin-6 and acute coronary syndrome. Clin. Cardiol. 24 (2001) 701-704
80. Iskra M., Patelski J., and Majewski W. Relationship of calcium, magnesium, zinc and copper concentrations in the arterial wall and serum in atherosclerosis obliterans and aneurysm. J. Trace Elem. Med. Biol. 11 (1997) 248-252
81. Jacobsen D.W. Hyperhomocysteinemia and oxidative stress: time for a reality check?. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1182-1184
82. Jenner A., Ren M., Rajendran R., Ning P., Huat B.T., Watt F., and Halliwell B. Zinc supplementation inhibits lipid peroxidation and the development of atherosclerosis in rabbits fed a high cholesterol diet. Free Radic. Biol. Med. 42 (2007) 559-566
83. Jerrard-Dunne P., Sitzer M., Risley P., Steckel D.A., Buehler A., von Kegler S., and Markus H.S. Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis. Stroke 34 (2003) 402-407
84. Jin X., Xiao C., Tanguay R.M., Yang L., Wang F., Chen M., Fu X., Wang R., Deng J., Deng Z., Zheng Y., Wei Q., and Wu T. Correlation of lymphocyte heat shock protein 70 levels with neurologic deficits in elderly patients with cerebral infarction. Am. J. Med. 117 (2004) 406-411
85. Jovinge S., Hamsten A., Tornvall P., Proudler A., Bavenholm P., Ericsson C.G., Godsland I., de Faire U., and Nilsson J. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism 47 (1998) 113-118
86. Kahmann L., Uciechowski P., Warmuth S., Plümäkers B., Gressner A.M., Malavolta M., Mocchegiani E., and Rink L. Zinc supplementation in the elderly reduces spontaneous inflammatory. Rejuvenation Res. 11 (2008) 227-237
87. Kanekiyo M., Itoh N., Kawasaki A., Matsuyama A., Matsuda K., Nakanishi T., and Tanaka K. Metallothionein modulates lipopolysaccharide-stimulated tumour necrosis factor expression in mouse peritoneal macrophages. Biochem. J. 361 (2002) 363-369
88. Karin M., Lawrence T., and Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124 (2006) 823-835
89. Keso T., Perola M., Laippala P., Ilveskoski E., Kunnas T.A., Mikkelsson J., Penttilä A., Hurme M., and Karhunen P.J. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis 154 (2001) 691-697
90. Kiang J.G., and Tsokos G.C. Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol. Ther. 80 (1998) 183-201
91. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E., Willeit J., and Schwartz D.A. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347 (2002) 185-192
92. Kimura T., Itoh N., Takehara M., Oguro I., Ishizaki J., Nakanishi T., and Tanaka K. MRE-binding transcription factor-1 is activated during endotoxemia: a central role for metallothionein. Toxicol. Lett. 129 (2002) 77-84
93. Kitamura H., Morikawa H., Kamon H., Iguchi M., Hojyo S., Fukada T., Yamashita S., Kaisho T., Akira S., Murakami M., and Hirano T. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat. Immunol. 7 (2006) 971-977
94. Klosterhalfen B., Töns C., Hauptmann S., Tietze L., Offner F.A., Küpper W., and Kirkpatrick C.J. Influence of heat shock protein 70 and metallothionein induction by zinc-bis-(dl-hydrogenaspartate) on the release of inflammatory mediators in a porcine model of recurrent endotoxemia. Biochem. Pharmacol. 52 (1996) 1201-1210
95. Koch W., Kastrati A., Bottiger C., Mehilli J., von Beckerath N., and Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 159 (2001) 137-144
96. Koenig W., Khuseyinova N., Hoffmann M.M., Marz W., Frohlich M., Hoffmeister A., Brenner H., and Rothenbacher D. CD14 C (-260)→T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J. Am. Coll. Cardiol. 40 (2002) 34-42
97. Kube D., Rieth H., Eskdale J., Kremsner P.G., and Gallagher G. Structural characterisation of the distal 5' flanking region of the human interleukin-10 gene. Genes Immun. 2 (2001) 181-190
98. Kunzmann A., Dedoussis G., Jajte J., Malavolta M., Mocchegiani E., and Bürkle A. Effect of zinc on cellular poly(ADP-ribosyl)ation capacity. Exp. Gerontol. 43 (2007) 409-414
99. Labrum R., Bevan S., Sitzer M., Lorenz M., and Markus H.S. Toll receptor polymorphisms and carotid artery intima-media thickness. Stroke 38 (2007) 1179-1184
100. Lakshmikuttyamma A., Selvakumar P., and Sharma R.K. Interaction between heat shock protein 70 kDa and calcineurin in cardiovascular systems. Int. J. Mol. Med. 17 (2006) 419-423
101. Lee C.W., Lin C.C., Lin W.N., Liang K.C., Luo S.F., Wu C.B., Wang S.W., and Yang C.M. TNF-alpha induces MMP-9 expression via activation of Src/EGFR PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 292 (2007) L799-812
102. Lee D.H., Folsom A.R., and Jacobs Jr. D.R. Iron, zinc, and alcohol consumption and mortality from cardiovascular diseases: the Iowa Women's Health Study. Am. J. Clin. Nutr. 81 (2005) 787-791
103. Lee J.S., Lee J.J., and Seo J.S. HSP70 deficiency results in activation of c-Jun N-terminal Kinase, extracellular signal-regulated kinase, and caspase-3 in hyperosmolarity-induced apoptosis. J. Biol. Chem. 280 (2005) 6634-6641
104. Lee Y.H., Ji J.D., and Song G.G. Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J. Rheumatol. 34 (2007) 43-49
105. Leone N., Courbon D., Ducimetiere P., and Zureik M. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology 17 (2006) 308-314
106. Lio D., Annoni G., Licastro F., Crivello A., Forte G.I., Scola L., Colonna-Romano G., Candore G., Arosio B., Galimberti L., Vergani C., and Caruso C. Tumor necrosis factor-alpha -308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech. Ageing Dev. 127 (2006) 567-571
107. Lio D., Scola L., Crivello A., Colonna-Romano G., Candore G., Bonafe M., Cavallone L., Franceschi C., and Caruso C. Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun. 3 (2002) 30-33
108. Lio D., Scola L., Crivello A., Colonna-Romano G., Candore G., Bonafe M., Cavallone L., Marchegiani F., Olivieri F., Franceschi C., and Caruso C. Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10-1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J. Med. Genet. 40 (2003) 296-299
109. Lo S.K., Cheung A., Zheng Q., and Silverstein R.L. Induction of tissue factor on monocytes by adhesion to endothelial cells. J. Immunol. 154 (1995) 4768-4777
110. Longobardo M.T., Cefalù A.B., Pezzino F., Noto D., Emmanuele G., Barbagallo C.M., Fiore B., Monastero R., Castello A., Molini V., Notarbartolo A., Travali S., and Averna M.R. The C(-260) >T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction. Clin. Exp. Med. 3 (2003) 161-165
111. Loppnow H., Stelter F., Schonbeck U., Schluter C., Ernst M., Schutt C., and Flad H.D. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect. Immun. 63 (1995) 1020-1026
112. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., Mahieu P., Malaise M., De Groote D., Louis R., and Belaiche J. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin. Exp. Immunol. 113 (1998) 401-406
113. Luc G., Bard J.M., Juhan-Vague I., Ferrieres J., Evans A., Amouyel P., Arveiler D., Fruchart J.C., and Ducimetiere P. PRIME Study Group. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease. Arteriosler. Thromb. Vasc. Biol. 23 (2003) 1255-1261
114. Mackenzie G.G., Zago M.P., Keen C.L., and Oteiza P.I. Low intracellular zinc impairs the translocation of activated NF-kappa B to the nuclei in human neuroblastoma IMR-32 cells. J. Biol. Chem. 277 (2002) 34610-346177
115. Magder S., Neculcea J., Neculcea V., and Sladek R. Lipopolysaccharide and TNF-alpha produce very similar changes in gene expression in human endothelial cells. J. Vasc. Res. 43 (2006) 447-461
116. Maier W., Altwegg L.A., Corti R., Gay S., Hersberger M., Maly F.E., Sütsch G., Roffi M., Neidhart M., Eberli F.R., Tanner F.C., Gobbi S., von Eckardstein A., and Lüscher T.F. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 111 (2005) 1355-1361
117. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M.F., Soubrier F., Esposito B., Duez H., Fievet C., Staels B., Duverger N., Scherman D., and Tedgui A. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85 (1999) 17-24
118. Maret W., Jacob C., Vallee B.L., and Fischer E.H. Inhibitory sites in enzymes: zinc removal and reactivation by thionein. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 1936-1940
119. Maret W., and Krezel A. Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol. Med. 13 (2007) 371-375
120. Mariani E., Mangialasche F., Feliziani F.T., Cecchetti R., Malavolta M., Bastioni P., Baglioni M., Dedoussis G., Fulop T., Herbein G., Jajte J., Monti D., Rink L., Mocchegiani E., and Mecocci P. Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. Exp. Gerontol. 43 (2007) 445-451
121. Marini M., Lapalombella R., Canaider S., Farina A., Monti D., De Vescovi V., Morellini M., Bellizzi D., Dato S., De Benedictis G., Passarino G., Moresi R., Tesei S., and Franceschi C. Heat shock response by EBV-immortalized B-lymphocytes from centenarians and control subjects: a model to study the relevance of stress response in longevity. Exp. Gerontol. 39 (2004) 83-90
122. Martin-Lagos F., Navarro-Alarcon M., Terres-Martos C., Lopez G., de la Serena H., and Lopez-Martinez M.C. Serum copper and zinc concentrations in serum from patients with cancer and cardiovascular disease. Sci. Total Environ. 204 (1997) 27-35
123. Martin-Moreno, J.M., et al., 2003. Myocardial infarction risk in relation to zinc concentration in toenails. Br. J. Nutr. 89, 673-678.
124. Martin-Ventura J.L., Leclercq A., Blanco-Colio L.M., Egido J., Rossignol P., Meilhac O., and Michel J.B. Low plasma levels of HSP70 in patients with carotid atherosclerosis are associated with increased levels of proteolytic markers of neutrophil activation. Atherosclerosis 194 (2007) 334-341
125. Mazzatti D.J., Malavolta M., White A.J., Costarelli L., Giacconi R., Muti E., Cipriano C., Powell J.R., and Mocchegiani E. Differential effects of in vitro zinc treatment on gene expression in peripheral blood mononuclear cells derived from young and elderly individuals. Rejuvenation Res. 10 (2007) 603-620
126. Meerarani P., Ramadass P., Toborek M., Bauer H.C., Bauer H., and Hennig B. Zinc protects against apoptosis of endothelial cells induced by linoleic acid and tumor necrosis factor alpha. Am. J. Clin. Nutr. 71 (2000) 81-87
127. Metz C.H., Schröder A.K., Overbeck S., Kahmann L., Plümäkers B., and Rink L. T-helper type 1 cytokine release is enhanced by in vitro zinc supplementation due to increased natural killer cells. Nutrition 23 (2007) 157-163
128. Metzler B., Abia R., Ahmad M., Wernig F., Pachinger O., Hu Y., and Xu Q. Activation of heat shock transcription factor 1 in atherosclerosis. Am. J. Pathol. 162 (2003) 1669-1676
129. Michelsen K.S., Doherty T.M., Shah P.K., and Arditi M. TLR signaling: an emerging bridge from innate immunity to atherogenesis. J. Immunol. 173 (2004) 5901-5907
130. Mielcarz G., Howard A.N., Mielcarz B., Williams N.R., Rajput-Williams J., Nigdigar S.V., and Stone D.L. Leucocyte copper, a marker of copper body status is low in coronary artery disease. J. Trace Elem. Med. Biol. 15 (2001) 31-35
131. Mocchegiani E., Costarelli L., Giacconi R., Cipriano C., Muti E., Tesei S., and Malavolta M. Nutrient-gene interaction in ageing and successful ageing. A single nutrient (zinc) and some target genes related to inflammatory/immune response. Mech. Ageing Dev. 127 (2006) 517-525
132. Mocchegiani E., Giacconi R., Cipriano C., Costarelli L., Muti E., Tesei S., Giuli C., Papa R., Marcellini F., Mariani E., Rink L., Herbein G., Varin A., Fulop T., Monti D., Jajte J., Dedoussis G., Gonos E.S., Trougakos I.P., and Malavolta M. Zinc, metallothioneins, and longevity: effect of zinc supplementation: zincage study. Ann. N.Y. Acad. Sci. 1119 (2007) 129-146
133. Mocchegiani E., Giacconi R., Cipriano C., Muzzioli M., Gasparini N., Moresi R., Stecconi R., Suzuki H., Cavalieri E., and Mariani E. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp. Gerontol. 37 (2002) 349-357
134. Mocchegiani E., Giacconi R., Costarelli L., Muti E., Cipriano C., Tesei S., Pierpaoli S., Giuli C., Papa R., Marcellini F., Gasparini N., Pierandrei R., Piacenza F., Mariani E., Dedoussis G., Kanoni S., Herbein G., Fulop T., Rink L., Jajte J., and Malavolta M. Zinc deficiency and IL-6 polymorphism in old people from different European countries: effect of zinc supplementation. Zincage study. Exp. Gerontol. 43 (2008) 433-444
135. Mocchegiani E., Muzzioli M., and Giacconi R. Zinc and immunoresistance to infection in aging: new biological tools. Trends Pharmacol. Sci. 21 (2000) 205-208
136. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
137. Morange P.E., Saut N., Alessi M.C., Frere C., Hawe E., Yudkin J.S., Tremoli E., Margaglione M., Di Minno G., Hamsten A., Humphries S.E., and Juhan-Vague I. HIFMECH Study Group. Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study. Atherosclerosis 179 (2005) 317-323
138. Mullins J.E., and Fuentealba I.C. Immunohistochemical detection of metallothionein in liver, duodenum and kidney after dietary copper-overload in rats. Histol. Histopathol. 13 (1998) 627-633
139. Naya M., Tsukamoto T., Morita K., Katoh C., Furumoto T., Fujii S., Tamaki N., and Tsutsui H. Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients. Hypertens. Res. 30 (2007) 541-548
140. Nebel A., Flachsbart F., Schafer A., Nothnagel M., Nikolaus S., Mokhtari N.E., and Schreiber S. Role of the toll-like receptor 4 polymorphism Asp299Gly in longevity and myocardial infarction in German men. Mech. Ageing Dev. 128 (2007) 409-411
141. Olivieri F., Bonafe M., Cavallone L., Giovanetti S., Marchigiani F., Cardelli M., Mugianesi E., Giampieri C., Moresi R., Stecconi R., Lisa R., and Franceschi C. The -174 C/G locus affects in vitro/in vivo IL-6 production during aging. Exp. Gerontol. 37 (2002) 309-314
142. O'Reilly S.M., and Moynagh P.N. Regulation of Toll-like receptor 4 signalling by A20 zinc finger protein. Biochem. Biophys. Res. Commun. 303 (2003) 586-593
143. Padovani J.C., Pazin-Filho A., Simões M.V., Marin-Neto J.A., Zago M.A., and Franco R.F. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb. Res. 100 (2000) 263-269
144. Papatheodorou L., and Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid. Redox Signal. 9 (2007) 1941-1958
145. Park M.H., Min J.Y., Koh S.B., Kim B.J., Park M.K., Park K.W., and Lee D.H. Helicobacter pylori infection and the CD14 C (-260)T gene polymorphism in ischemic stroke. Thromb. Res. 118 (2006) 671-677
146. Peterson D.G., Scrimgeour A.G., McClung J.P., and Koutsos E.A. Moderate zinc restriction affects intestinal health and immune function in lipopolysaccharide-challenged mice. J. Nutr. Biochem. 19 (2008) 193-199
147. Pinderski L.J., Fischbein M.P., Subbanagounder G., Fishbein M.C., Kubo N., Cheroutre H., Curtiss L.K., Berliner J.A., and Boisvert W.A. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ. Res. 90 (2002) 1064-1071
148. Pockley A.G., Georgiades A., Thulin T., de Faire U., and Frostegard J. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 42 (2003) 235-238
149. Pola R., Flex A., Gaetani E., Flore R., Serricchio M., and Pola P. Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 34 (2003) 881-885
150. Pradhan A.D., Manson J.E., Rossouw J.E., Siscovick D.S., Mouton C.P., Rifai N., Wallace R.B., Jackson R.D., Pettinger M.B., and Ridker P.M. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. JAMA 288 (2002) 980-987
151. Prasad A.S. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J. Infect. Dis. 182 (2000) S62-68
152. Prasad A.S., Bao B., Beck F.W., Kucuk O., and Sarkar F.H. Antioxidant effect of zinc in humans. Free Radic. Biol. Med. 37 (2004) 1182-1190
153. Prasad A.S., Beck F.W., Bao B., Fitzgerald J.T., Snell D.C., Steinberg J.D., and Cardozo L.J. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am. J. Clin. Nutr. 85 (2007) 837-844
154. Pugin J., Ulevitch R.J., and Tobias P.S. Activation of endothelial cells by endotoxin: direct versus indirect pathways and the role of CD14. Prog. Clin. Biol. Res. 392 (1995) 369-373
155. Putics A., Vödrös D., Malavolta M., Mocchegiani E., Csermely P., and So{combining double acute accent}ti C. Zinc supplementation boosts the stress response in the elderly: Hsp70 status is linked to zinc availability in peripheral lymphocytes. Exp. Gerontol. 43 (2008) 452-461
156. Rauramaa R., Väisänen S.B., Luong L.A., Schmidt-Trücksäss A., Penttilä I.M., Bouchard C., Töyry J., and Humphries S.E. Stromeolysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2657-2662
157. Ren M., Rajendran R., Ning P., Kwong T., Huat B., Choon, Nam O., Watt F., Jenner A., and Halliwell B. Zinc supplementation decreases the development of atherosclerosis in rabbits. Free Radic. Biol. Med. 41 (2006) 222-225
158. Reunanen A., Knekt P., Marniemi J., Maki J., Maatela J., and Aromaa A. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur. J. Clin. Nutr. 50 (1996) 431-437
159. Rundek T., Elkind M.S., Pittman J., Boden-Albala B., Martin S., Humphries S.E., Juo S.H., and Sacco R.L. Carotid intima-media thickness is associated with allelic variants of stromeolysin-1, interleukin-6, and hepatic lipase genes. The Northern Manhattan Prospective Cohort Study. Stroke 33 (2002) 1420-1423
160. Sato K., Nagayama H., Tadokoro K., Juji T., and Takahashi T.A. Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in IL-10-mediated selective repression of TNF-alpha-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells. J. Immunol. 162 (1999) 3865-3872
161. Sato M., and Kondoh M. Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J. Exp. Med. 196 (2002) 9-22
162. Sbarsi I., Falcone C., Baiocchi C., Campo I., Zorzetto M., De Silvestri A., and Cuccia M. Inflammation and atherosclerosis: the role of TNF and TNF receptors polymorphisms in coronary artery disease. Int. J. Immunopathol. Pharmacol. 20 (2007) 145-154
163. Schroder N.W., and Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 5 (2005) 156-164
164. Seino Y., Ikeda U., Ikeda M., Yamamoto K., Misawa Y., Hasegawa T., Kano S., and Shimada K. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 6 (1994) 87-91
165. Sekuri, C., Cam, F.S., Sagcan, A., Ercan, E., Tengiz, I., Alioglu, E., Berdeli, A., 2007. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort. Coron. Artery Dis. 18, 333-337.
166. Selhub J., Jacques P.F., Wilson P.W., Rush D., and Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270 (1993) 2693-2698
167. Shimada A., Yanagida M., and Umemura T. An immunohistochemical study on the tissue-specific localization of metallothionein in dogs. J. Comp. Pathol. 116 (1997) 1-11
168. Shimada K., Miyauchi K., Mokuno H., Watanabe Y., Iwama Y., Shigekiyo M., Matsumoto M., Okazaki S., Tanimoto K., Kurata T., Sato H., and Daida H. Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting. Int. J. Cardiol. 94 (2004) 87-92
169. Shin H.J., Lee H., Park J.D., Hyun H.C., Sohn H.O., Lee D.W., and Kim Y.S. Kinetics of binding of LPS to recombinant CD14, TLR4, and MD-2 proteins. Mol. Cells. 24 (2007) 119-124
170. Sie M.P., Sayed-Tabatabaei F.A., Oei H.H., Uitterlinden A.G., Pols H.A., Hofman A., van Duijn C.M., and Witteman J.C. Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 212-217
171. Singh R.B., Niaz M.A., Rastogi S.S., Bajaj S., Gaoli Z., and Shoumin Z. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J. Am. Coll. Nutr. 17 (1998) 564-570
172. Sistonen L., Sarge K.D., and Morimoto R.I. Human heat shock factors 1 and 2 are differentially activated and can synergistically induce hsp70 gene transcription. Mol. Cell. Biol. 14 (1994) 2087-2099
173. Smith D.A., Irving S.D., Sheldon J., Cole D., and Kaski J.C. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104 (2001) 746-749
174. 2+ release. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13952-13957
175. Sukovich D.A., Kaiser K., Shirley F.D., Del Vecchio V., Halks-Miller M., and Rubanyi G.M. Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17beta-estradiol. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1498-1505
176. Svensson P.A., Asea A., Englund M.C., Bausero M.A., Jernas M., Wiklund O., Ohlsson B.G., Carlsson L.M., and Carlsson B. Major role of HSP70 as a paracrine inducer of cytokine production in human oxidized LDL treated macrophages. Atherosclerosis 185 (2006) 32-38
177. Tang V., Dhirapong A., Yabes A.P., and Weiss R.H. TNF-alpha-mediated apoptosis in vascular smooth muscle cells requires p73. Am. J. Physiol. Cell Physiol. 289 (2005) C199-206
178. Terry D.F., McCormick M., Andersen S., Pennington J., Schoenhofen E., Palaima E., Bausero M., Ogawa K., Perls T.T., and Asea A. Cardiovascular disease delay in centenarian offspring: role of heat shock proteins. Ann. N.Y. Acad. Sci. 1019 (2004) 502-505
179. Terry D.F., Wyszynski D.F., Nolan V.G., Atzmon G., Schoenhofen E.A., Pennington J.Y., Andersen S.L., Wilcox M.A., Farrer L.A., Barzilai N., Baldwin C.T., and Asea A. Serum heat shock protein 70 level as a biomarker of exceptional longevity. Mech. Ageing Dev. 127 (2006) 862-868
180. Tsan M.F., and Gao B. Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76 (2004) 514-519
181. Tuomisto K., Jousilahti P., Sundvall J., Pajunen P., and Salomaa V. C-reactive protein, interleukin-6 and tumor necrosis factor a as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb. Haemost. 95 (2006) 511-518
182. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 24 (1997) 1-8
183. Uematsu S., and Akira S. The role of Toll-like receptors in immune disorders. Expert. Opin. Biol. Ther. 6 (2006) 203-214
184. Ulevitch R.J., and Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13 (1995) 437-457
185. Van Den Biggelaar A.H.J., De Craen A.J.M., Gussekloo J., Huizinga J., Heijmans B.T., Frölich M., Kirkwood T.B.L., and Westendorp R.G.J. Inflammation underlying cardiovascular mortality is a late consequence of evolutionary programming. FASEB J. 18 (2004) 1022-1024
186. Van Molle W., Van Roy M., Van Bogaert T., Dejager L., Van Lint P., Vanlaere I., Sekikawa K., Kollias G., and Libert C. Protection of zinc against tumor necrosis factor induced lethal inflammation depends on heat shock protein 70 and allows safe antitumor therapy. Cancer Res. 67 (2007) 7301-7307
187. Vasak M., and Kägi J.H.R. Spectroscopic properties of metallothionein. In: Helmut Siegel (Ed). Metal Ions in Biological Systems (1983), Marcel Dekker Inc., New York 213-273
188. Vasto S., Mocchegiani E., Malavolta M., Cuppari I., Listi F., Nuzzo D., Ditta V., Candore G., and Caruso C. Zinc and inflammatory/immune response in aging. Ann. N.Y. Acad. Sci. 1100 (2007) 111-122
189. Vendrell J., Fernandez-Real J.M., Gutierrez C., Zamora A., Simon I., Bardaji A., Ricart W., and Richart C. A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 167 (2003) 257-264
190. Vila E., and Salaices M. Cytokines and vascular reactivity in resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H1016-1021
191. von Bülow V., Dubben S., Engelhardt G., Hebel S., Plümäkers B., Heine H., Rink L., and Haase H. Zinc-dependent suppression of TNF-alpha production is mediated by protein kinase A-induced inhibition of Raf-1, I kappa B kinase beta, and NF-kappa B. J. Immunol. 179 (2007) 4180-4186
192. von Bülow V., Rink L., and Haase H. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3′,5′-cyclic monophosphate. J. Immunol. 175 (2005) 4697-4705
193. Webb G.C., and Chaplin D.D. Genetic variability at the human tumor necrosis factor loci. J. Immunol. 145 (1990) 1278-1285
194. West A.K., Stallings R., Hildebrand C.E., Chiu R., Karin M., and Richards R.I. Human metallothionein genes: structure of the functional locus at 16q13. Genomics 8 (1990) 513-518
195. Westendorp R.G., Langermans J.A., Huizinga T.W., Verweij C.L., and Sturk A. Genetic influence on cytokine production in meningococcal disease. Lancet 349 (1997) 1912-1913
196. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 3195-3199
197. Wolfrum S., Teupser D., Tan M., Chen K.Y., and Breslow J.L. The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 18601-18606
198. Xu Q., Dietrich H., Steiner H.J., Gown A.M., Schoel B., Mikuz G., Kaufmann S.H., and Wick G. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler. Thromb. 12 (1992) 789-799
199. Yang X., Coriolan D., Murthy V., Schultz K., Golenbock D.T., and Beasley D. Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H1069-1076
200. Young J.L., Libby P., and Schönbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb. Haemost. 88 (2002) 554-567
201. Yousef M.I., El-Hendy H.A., El-Demerdash F.M., and Elagamy E.I. Dietary zinc deficiency induced-changes in the activity of enzymes and the levels of free radicals, lipids and protein electrophoretic behavior in growing rats. Toxicology 175 (2002) 223-234
202. Zee R.Y., Bates D., and Ridker P.M. A prospective evaluation of the heat shock protein 70 gene polymorphisms and the risk of stroke. Thromb. Haemost. 87 (2002) 622-625
203. Zee R.Y., Lindpaintner K., Struk B., Hennekens C.H., and Ridker P.M. A prospective evaluation of the CD14 C (-260)T gene polymorphism and the risk of myocardial infarction. Atherosclerosis 154 (2001) 699-702
204. Zhou Z., Connell M.C., and MacEwan D.J. TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal. 19 (2007) 1238-1248
205. Zhu J., Quyyumi A.A., Wu H., Csako G., Rott D., Zalles-Ganley A., Ogunmakinwa J., Halcox J., and Epstein S.E. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1055-1059
206. ZINCAGE Project, 2004-2007. http://www.zincage.org